| Authors: |
Scanlon PH; Gloucestershire Retinal Research Group, Cheltenham General Hospital, Cheltenham, UK.; Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, England.; University of Gloucestershire, Cheltenham, England., Nevill CR; Gloucestershire Retinal Research Group, Cheltenham General Hospital, Cheltenham, UK., Stratton IM; Gloucestershire Retinal Research Group, Cheltenham General Hospital, Cheltenham, UK., Maruti SS; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA., Massó-González EL; Boehringer Ingelheim International GmBH, Ingelheim, Germany., Sivaprasad S; Moorfields Eye Hospital, London, UK., Bailey C; Bristol Eye Hospital, Bristol, UK., Ehrlich M; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA., Chong V; Boehringer Ingelheim International GmBH, Ingelheim, Germany. |
